| Title: | ALTANA AKTIENGESELLSCHAFT-DETAILED PRODUCT PIPELINE |
| Price: | $1,480.00 |
| Publication Date: | Jan 29, 2007 |
| Source: | LIFE SCIENCE ANALYTICS |
| Brief Excerpt: | ...ALTANA Aktiengesellschaft engages in the development, manufacture, and marketing of pharmaceutical and chemical products for various applications worldwide. It operates in two segments, Pharmaceuticals and Chemicals. The Pharmaceuticals division develops therapeutic products primarily for the treatment of gastrointestinal and respiratory diseases. Its primary product candidate, Pantoprazole is a proton pump inhibitor for the treatment of ulcers and reflux disease. This division also offers Ciclesonide for the treatment of asthma, as a metered dose inhaler; develops Roflumilast, a drug candidate for the treatment of asthma and chronic obstructive pulmonary diseases; imaging reagents; and over -the-counter drugs comprising gastrointestinal drugs, pain killers, tonics, and vitamins. The Chemicals division offers various specialty chemicals, including additives and measuring instruments, metallic effect pigments and printing inks, coatings and sealing compounds, and electrical... |
| Length: | 37 Pages |
| Company: | ALTANA |
| Geographic Regions: | EUROPE, GERMANY, WESTERN EUROPE REGION |
| Format: | 
Adobe Acrobat
|
Looking For Something Else?
